J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

Elixir trails J&J’s Shockwave but has outpaced Bolt Medical to the European market with its mechanical IVL system.

The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s coronary intravascular lithotripsy (IVL) system in a clinical trial.

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that ... billion buy of Shockwave Medical.

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular lithotripsy (IVL) system, positioning ...

Abbott announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment ...

Intravascular Lithotripsy System (IVL) in Europe. The first cases were completed by Stefano Galli, MD, Interventional Cardiologist at Centro Cardiologico Monzino in Milan, Italy; Professor Eric ...

Around 700 patients treated with ESWL at Government Rajaji Hospital after new machine installed, resolving previous technical issues.

The North-Chicago based company announced today that the U.S. Food & Drug Administration gave investigational device exemption to Abbott's coronary intravascular lithotripsy system. The trial will ...

Elixir Medical announced today that it received CE mark for its LithiX hertz contact (HC) intravascular lithotripsy (IVL) ...

for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment of severe calcification in coronary arteries prior to stenting. The TECTONIC Coronary Artery Disease (CAD ...